1. Home
  2. GL vs ROIV Comparison

GL vs ROIV Comparison

Compare GL & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GL
  • ROIV
  • Stock Information
  • Founded
  • GL 1900
  • ROIV 2014
  • Country
  • GL United States
  • ROIV United Kingdom
  • Employees
  • GL N/A
  • ROIV N/A
  • Industry
  • GL Life Insurance
  • ROIV Biotechnology: Pharmaceutical Preparations
  • Sector
  • GL Finance
  • ROIV Health Care
  • Exchange
  • GL Nasdaq
  • ROIV Nasdaq
  • Market Cap
  • GL 9.3B
  • ROIV 8.4B
  • IPO Year
  • GL N/A
  • ROIV N/A
  • Fundamental
  • Price
  • GL $118.37
  • ROIV $11.15
  • Analyst Decision
  • GL Buy
  • ROIV Strong Buy
  • Analyst Count
  • GL 10
  • ROIV 8
  • Target Price
  • GL $134.00
  • ROIV $17.93
  • AVG Volume (30 Days)
  • GL 708.9K
  • ROIV 5.3M
  • Earning Date
  • GL 02-05-2025
  • ROIV 02-11-2025
  • Dividend Yield
  • GL 0.81%
  • ROIV N/A
  • EPS Growth
  • GL 22.14
  • ROIV N/A
  • EPS
  • GL 11.80
  • ROIV 5.89
  • Revenue
  • GL $5,727,483,000.00
  • ROIV $129,128,999.00
  • Revenue This Year
  • GL N/A
  • ROIV $15.98
  • Revenue Next Year
  • GL $5.63
  • ROIV N/A
  • P/E Ratio
  • GL $10.02
  • ROIV $1.98
  • Revenue Growth
  • GL 6.72
  • ROIV 145.68
  • 52 Week Low
  • GL $38.95
  • ROIV $9.69
  • 52 Week High
  • GL $132.00
  • ROIV $13.06
  • Technical
  • Relative Strength Index (RSI)
  • GL 72.64
  • ROIV 44.16
  • Support Level
  • GL $110.43
  • ROIV $10.89
  • Resistance Level
  • GL $114.49
  • ROIV $11.26
  • Average True Range (ATR)
  • GL 2.34
  • ROIV 0.36
  • MACD
  • GL 0.70
  • ROIV -0.05
  • Stochastic Oscillator
  • GL 95.33
  • ROIV 41.01

About GL Globe Life Inc.

Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into four reportable segments: life insurance, supplemental health insurance, annuities, and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: